A startup based in Albuquerque, N.M., said Wednesday it has secured funding for construction of a 2-megawatt reactor facility for production of the medical isotope molybdenum-99.
Eden Radioisotopes plans in four years to begin production at the reactor and processing…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.





